| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $27,544,362 ) (Continued on the next page) |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R61DA064788 | Recovery Inspired Support Engagement (RISE) | 000 | 1 | NIH | 3/6/2026 | $453,654 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH134885 | 3/5- Biomarkers to Enhance Early Schizophrenia Treatment (BEEST) | 000 | 3 | NIH | 7/29/2026 | $413,754 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH137459 | A Multilevel Characterization of Sensory Cortical Disinhibition in Post-Traumatic Intrusions | 000 | 3 | NIH | 7/31/2026 | $179,117 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01NS129188 | Human iPSC-Based Personalized Cell Therapy of PD | 000 | 4 | NIH | 5/5/2026 | $689,100 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01NS127391 | Crosstalk Between Nurr1 and Risk Factors of Parkinson's Disease and its Regulation by Nurr1's Ligands | 000 | 4 | NIH | 5/1/2026 | $432,440 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23DA063863 | Identifying individual clinical and environmental predictors of buprenorphine response to inform treatment for opioid use disorder | 000 | 1 | NIH | 5/25/2026 | $194,206 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA066062 | Longitudinal Cohort Study of Opioid Use Disorder | 000 | 1 | NIH | 5/25/2026 | $736,811 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH135844 | Harnessing smartphones for real-time detection of affective disturbance and future depression risk in adolescents | 000 | 2 | NIH | 12/5/2025 | $669,159 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH135899 | Leveraging Machine Learning Approaches to Understand Mechanisms of Exposure Therapy in Real-World Settings | 000 | 3 | NIH | 4/1/2026 | $769,765 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH129374 | Parent interpretation bias as a key mechanism of intergenerational transmission of anxiety | 000 | 4 | NIH | 5/19/2026 | $743,794 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH134074 | Imaging the Functional State of the D2high Receptor in drug induced dopamine supersensitivity in schizophrenia | 000 | 3 | NIH | 1/28/2026 | $666,559 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH137075 | Personalized Quality of Life Measurement | 000 | 3 | NIH | 4/1/2026 | $549,472 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH126000 | Empirical validation of a cerebellar-cortical hallucination circuit | 000 | 5 | NIH | 12/10/2025 | $572,264 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH126000 | Empirical validation of a cerebellar-cortical hallucination circuit | 001 | 5 | NIH | 8/23/2026 | $0 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01AA030585 | Insula-amygdala circuits in alcohol abuse | 000 | 4 | NIH | 7/29/2026 | $516,261 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K00HD112293 | Elucidating interactions among early life adversity, sleep architecture, and immune function | 000 | 6 | NIH | 1/8/2026 | $103,215 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH135093 | Molecular Mechanisms of Aging in Schizophrenia: Implications of Bioenergetic Metabolism and Redox Biology | 000 | 3 | NIH | 12/12/2025 | $888,999 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH132900 | Shared and differential vulnerabilities of stress and reward processing in psychosis-risk syndromes or early-stage depression | 000 | 3 | NIH | 12/3/2025 | $178,416 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA058315 | Impact of prescription stimulants on the drug overdose epidemic | 000 | 4 | NIH | 3/23/2026 | $714,786 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K08MH130802 | Understanding Foxp2-Mediated Molecular Signaling in Fear Learning | 000 | 4 | NIH | 6/25/2026 | $193,993 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH139697 | Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression | 000 | 2 | NIH | 5/26/2026 | $680,594 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | T32MH125786 | Training to Enhance Alignment of Psychiatry and Neuroscience | 001 | 5 | NIH | 4/17/2026 | $3,000 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K01MH129828 | Multimodal characterization of affective visual processing in the early aftermath of trauma | 000 | 4 | NIH | 12/1/2025 | $179,707 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | P50MH115846 | Laboratory for Early Psychosis Research (LEAP) | 000 | 8 | NIH | 8/17/2026 | $1,951,130 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH117292 | Site 3/3, Understanding PTSD through Postmortem Targeted Brain Multiomics | 000 | 7 | NIH | 2/25/2026 | $902,371 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH137441 | Tracking the dynamic trajectory of behavioral, physiological, and neurobiological stress responses in female adolescents at high and low familial risk for depression. | 000 | 2 | NIH | 4/27/2026 | $705,959 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA047575 | Neural and Behavioral Consequences of Chronic THC Exposure During Adolescence | 000 | 7 | NIH | 3/30/2026 | $1,235,789 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K24AA025977 | Mentoring in Patient-Oriented Neuroscience Research | 000 | 10 | NIH | 8/12/2026 | $162,796 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | T32DA015036 | Training in Drug Abuse and Brain Imaging | 000 | 25 | NIH | 5/22/2026 | $148,319 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K24DA061976 | Mentoring in Patient-Oriented Research on Substance Use Disorders | 000 | 2 | NIH | 1/28/2026 | $208,575 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH126193 | Interpretation Bias as a Mechanism of Treatment Response in OCD | 000 | 5 | NIH | 5/20/2026 | $181,743 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23DA061913 | Written Exposure Therapy embedded into residential substance use treatment: Efficacy and mechanisms for co-occurring substance use and PTSD | 002 | 1 | NIH | 7/10/2026 | $0 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23DA061913 | Written Exposure Therapy embedded into residential substance use treatment: Efficacy and mechanisms for co-occurring substance use and PTSD | 001 | 1 | NIH | 3/20/2026 | $0 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23DA061913 | Written Exposure Therapy embedded into residential substance use treatment: Efficacy and mechanisms for co-occurring substance use and PTSD | 000 | 1 | NIH | 2/19/2026 | $193,320 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH137400 | Online social networking mechanisms of suicide in adolescents | 000 | 1 | NIH | 2/18/2026 | $193,320 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | RF1MH136052 | MDMA Mechanisms of Prohedonic Efficacy: A Reverse Translational Approach | 000 | 2 | NIH | 4/24/2026 | $2,876,123 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH145639 | Trauma Recovery via EEG and Actigraphy Tracking (TREAT): Biomarkers of Written Exposure Therapy in PTSD | 000 | 1 | NIH | 8/20/2026 | $819,998 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K01MH138555 | Neurocognitive mechanisms of the negative retrieval bias in depression | 000 | 1 | NIH | 6/23/2026 | $179,096 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R61AT013127 | PAIN: Project Assessing the Mechanisms and Impact of a Novel Cannabinoid Product | 000 | 1 | NIH | 7/22/2026 | $1,687,494 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | F32DA067053 | Individualized Modeling of Neurodevelopmental Network Dynamics Predicting Cannabis Risk and Escalation in Adolescence | 000 | 1 | NIH | 8/7/2026 | $79,780 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01AG080636 | ApoE, lipid and immune mechanisms of human neurons and glia | 001 | 2 | NIH | 3/9/2026 | $76,143 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01AG080636 | ApoE, lipid and immune mechanisms of human neurons and glia | 000 | 2 | NIH | 12/17/2025 | $685,289 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH146063 | Pilot Hybrid Effectiveness-Implementation Trial of a Scalable Intervention Targeting Postpartum Intrusive Thoughts | 000 | 1 | NIH | 8/10/2026 | $410,000 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21DA062815 | Development of a biometrics-based platform to predict relapse | 000 | 1 | NIH | 5/14/2026 | $451,000 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | UH3DA058544 | Antibody-based therapy for fentanyl-related opioid use disorder | 000 | 2 | NIH | 2/9/2026 | $3,657,445 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R61DA064788 | Recovery Inspired Support Engagement (RISE) | 001 | 1 | NIH | 4/28/2026 | $0 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH138861 | Observing brain lactate dynamics during a working memory task in first episode and chronic schizophrenia | 000 | 2 | NIH | 2/5/2026 | $205,000 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | UG3DA062906 | Development and Validation of a Measure of Substance-Related Consequences: A Novel Clinical Outcome Assessment for Substance Use Disorder Trials | 000 | 2 | NIH | 8/12/2026 | $346,324 |
| | 2026 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH133268 | Next steps for PTSD genomics: from loci to function | 002 | 2 | NIH | 8/19/2026 | $0 |
|
